Griffipavixanthone from Garcinia oblongifolia champ induces cell apoptosis in human non-small-cell lung cancer H520 cells in Vitro

Molecules

Volumn 19, Issue 2, 2014, Pages 1422-1431

  Shi, Jun Min ^a   Huang, Hui Juan ^a   Qiu, Sheng Xiang ^b   Feng, Shi Xiu ^c   Li, Xu E ^a  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b SOUTH CHINA INSTITUTE OF BOTANY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Apoptosis; Caspase; Griffipavixanthone; H520 cells; Mitochondrial transmembrane potential; ROS generation

Indexed keywords

ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE; XANTHONE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GARCINIA; HUMAN; ISOLATION AND PURIFICATION; LUNG NON SMALL CELL CANCER; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; GARCINIA; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; REACTIVE OXYGEN SPECIES; XANTHONES;

EID: 84894607295     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19021422     Document Type: Article

References (22)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Tran, Q.N. A novel method for finding non-small cell lung cancer diagnosis biomarkers. BMC Med. Genomics 2013, 6, 11-20.
3. Meoni, G.; Cecere, F.L.; Lucherini, E.; di Costanzo, F. Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents. J. Geriatr. Oncol. 2013, 4, 282-290.
4. Lynch, T.J.; Bell, D.W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R.A.; Brannigan, B.W.; Harris, P.L.; Haserlat, S.M.; Supko, J.G.; Haluska, F.G.; et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004, 350, 2129-2139.
5. Mayo, C.; Bertran-Alamillo, J.; Molina-Vila, M.Á.; Giménez-Capitán, A.; Costa, C.; Rosell, R. Pharmacogenetics of EGFR in lung cancer: Perspectives and clinical applications. Pharmacogenomics 2012, 13, 789-802.
6. Nakata, A.; Gotoh, N. Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer. Expert Opin. Ther. Targets 2012, 16, 771-781.
7. Galvani, E.; Alfieri, R.; Giovannetti, E.; Cavazzoni, A.; La Monica, S.; Galetti, M.; Fumarola, C.; Bonelli, M.; Mor, M.; Tiseo, M.; et al. Epidermal growth factor receptor tyrosine kinase inhibitors: Current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer. Curr. Pharm. Des. 2013, 19, 818-832.
8. Ayoola, A.; Barochia, A.; Belani, K.; Belani, C.P. Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: An update. Cancer Invest. 2012, 30, 433-446.
9. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
10. Xu, Y.J.; Cao, S.G.; Wu, X.H.; Lai, Y.H.; Tan, B.H.K.; Pereira, J.T.; Goh, S.H.; Venkatraman, G.; Harrison, L.J.; Sim, K.Y. Griffipavixanthone, a novel cytotoxic bixanthone from Garcinia griffithii and G. pavifolia. Tetrahedron Lett. 1998, 39, 9103-9106.
11. Feng, S.; Jiang, Y.; Li, J.; Qiu, S.; Chen, T. A new bixanthone derivative from the bark of Garcinia oblongifolia. Nat. Prod. Res. 2013, doi:10.1080/14786419.2013.841686.
12. Merza, J.; Aumond, M.C.; Rondeau, D.; Dumontet, V.; le Ray, A.M.; Séraphin, D.; Richomme, P. Prenylated xanthones and tocotrienols from Garcinia virgata. Phytochemistry 2004, 65, 2915-2920.
13. Owa, T.; Yoshino, H.; Yoshimatsu, K.; Nagasu, T. Cell cycle regulation in the G1 phase: A promising target for the development of new chemotherapeutic anticancer agents. Curr. Med. Chem. 2001, 8, 1487-1503.
14. Shan, T.; Ma, Q.; Guo, K.; Liu, J.; Li, W.; Wang, F.; Wu, E. Xanthones from mangosteen extracts as natural chemopreventive agents: Potential anticancer drugs. Curr. Mol. Med. 2011, 11, 666-677.
15. Aisha, A.F.; Abu-Salah, K.M.; Ismail, Z.; Majid, A.M. In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract. BMC Complement. Altern. Med. 2012, 20, 104-114.
16. Liu, Z.; Antalek, M.; Nguyen, L.; Li, X.; Tian, X.; Le, A.; Zi, X. The effect of gartanin, a naturally occurring xanthone in mangosteen juice, on the mTOR pathway, autophagy, apoptosis, and the growth of human urinary bladder cancer cell lines. Nutr. Cancer 2013, 65, 68-77.
17. Johnson, J.J.; Petiwala, S.M.; Syed, D.N.; Rasmussen, J.T.; Adhami, V.M.; Siddiqui, I.A.; Kohl, A.M.; Mukhtar, H. α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 2012, 33, 413-419.
18. Mizushina, Y.; Kuriyama, I.; Nakahara, T.; Kawashima, Y.; Yoshida, H. Inhibitory effects of α-mangostin on mammalian DNA polymerase, topoisomerase, and human cancer cell proliferation. Food Chem. Toxicol. 2013, 59, 793-800.
19. Pontius, A.; Krick, A.; Mesry, R.; Kehraus, S.; Foegen, S.E.; Müller, M.; Klimo, K.; Gerhäuser, C.; König, G.M. Monodictyochromes A and B, dimeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J. Nat. Prod. 2008, 71, 1793-1799.
20. Ondeyka, J.G.; Dombrowski, A.W.; Polishook, J.P.; Felcetto, T.; Shoop, W.L.; Guan, Z.; Singh, S.B. Isolation and insecticidal/anthelmintic activity of xanthonol, a novel bis-xanthone, from a non-sporulating fungal species. J. Antibiot. 2006, 59, 288-292.
21. Isaka, M.; Jaturapat, A.; Rukseree, K.; Danwisetkanjana, K.; Tanticharoen, M.; Thebtaranonth, Y. Phomoxanthones A and B, novel xanthone dimers from the endophytic fungus Phomopsis species. J. Nat. Prod. 2001, 64, 1015-1018.
22. Kagawa, S.; Gu, J.; Honda, T.; McDonnell, T.J.; Swisher, S.G.; Roth, J.A.; Fang, B. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin. Cancer Res. 2001, 7, 1474-1480.